Related references
Note: Only part of the references are listed.Nanoparticles as safe and effective delivery systems of antifungal agents: Achievements and challenges
Ghareb M. Soliman
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles
T. C. Moraes Moreira Carraro et al.
JOURNAL DE MYCOLOGIE MEDICALE (2017)
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Felix Bongomin et al.
JOURNAL OF FUNGI (2017)
Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?
Aline Raquel Voltan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin
Marlene Lopes et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Role of nanoparticle size, shape and surface chemistry in oral drug delivery
Amrita Banerjee et al.
JOURNAL OF CONTROLLED RELEASE (2016)
The antifungal effect of silver nanoparticles on Trichosporon asahii
Zhi-Kuan Xia et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
PLGA-based nanoparticles: A new paradigm in biomedical applications
Shweta Sharma et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2016)
Amphotericin B-loaded polymeric nanoparticles: formulation optimization by factorial design
Talita Cristina Moreira Moraes Carraro et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2016)
Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles
A. C. O. Souza et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Cellular uptake, antioxidant and antiproliferative activity of entrapped α-tocopherol and γ-tocotrienol in poly (lactic-co-glycolic) acid (PLGA) and chitosan covered PLGA nanoparticles (PLGA-Chi)
Saeed Alqahtani et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2015)
Poly(L-lactide) Nanoparticles Reduce Amphotericin B Cytotoxicity and Maintain Its In Vitro Antifungal Activity
Diani Meza Casa et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2015)
Bovine Serum Albumin Nanoparticles Containing Amphotericin B: Characterization, Cytotoxicity and In Vitro Antifungal Evaluation
Diani Meza Casa et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2015)
Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization
Bushra T. AL-Quadeib et al.
SAUDI PHARMACEUTICAL JOURNAL (2015)
Reviewing the importance and evolution of fungal infections and potential antifungal resistance in haematological patients
Alessandro Busca et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2015)
Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation
Yuangang Zu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Distribution of Candida species isolated from blood cultures in hospitals in Osaka, Japan
Daiichi Morii et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2014)
Clinical practice guidelines for the management of invasive Candida infections in adults in the Middle East region: Expert panel recommendations
Adel F. Alothman et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2014)
Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days
Sara M. Navarro et al.
THERAPEUTIC DELIVERY (2014)
Pharmaceutical nanotechnology for oral delivery of anticancer drugs
Lin Mei et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Brazilian guidelines for the management of candidiasis - a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical
Arnaldo Lopes y Colombo et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
Richard J. Hamill
DRUGS (2013)
Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations
Dolores R. Serrano et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Antifungal Activity of Nanocapsule Suspensions Containing Tea Tree Oil on the Growth of Trichophyton rubrum
F. C. Flores et al.
MYCOPATHOLOGIA (2013)
Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment
Michael A. Pfaller
AMERICAN JOURNAL OF MEDICINE (2012)
Candidemia and invasive candidiasis in the adult: Clinical forms and treatment
Carlos Cervera
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2012)
Invasive fungal infections in patients with cancer in the Intensive Care Unit
Nikolaos V. Sipsas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
PLGA nanoparticles and nanosuspensions with amphotericin B: Potent in vitro and in vivo alternatives to Fungizone and AmBisome
H. Van de Ven et al.
JOURNAL OF CONTROLLED RELEASE (2012)
The Spanish Society of Paediatric Infectious Diseases (SEIP) recommendations on the diagnosis and management of invasive candidiasis
C. Figueras et al.
ANALES DE PEDIATRIA (2011)
Nanomedicine, nanotechnology in medicine
Patrick Boisseau et al.
COMPTES RENDUS PHYSIQUE (2011)
Guidelines for the treatment of invasive candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update
Jose Maria Aguado et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2011)
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems-A review
Susanne Fredenberg et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Candida albicans biofilms formed into catheters and probes and their resistance to amphotericin B
Z. Boucherit-Atmani et al.
JOURNAL DE MYCOLOGIE MEDICALE (2011)
Emerging opportunistic yeast infections
Marisa H. Miceli et al.
LANCET INFECTIOUS DISEASES (2011)
Nanosomal Amphotericin B is an efficacious alternative to Ambisome® for fungal therapy
Saifuddin Sheikh et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Pharmaceutical nanotechnology: Unmet needs in drug delivery
Daan J. A. Crommelin et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Present situation in the treatment of invasive fungal infection
Ben E. de Pauw et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Amphotericin B formulations and drug targeting
J. J. Torrado et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles
Manoj Nahar et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2008)
Antimicrobial effects of silver nanoparticles
Jun Sung Kim et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2007)
Amphotericin B nephrotoxicity: an update
B. Deroure et al.
JOURNAL DE MYCOLOGIE MEDICALE (2006)
Interactions of the drug amphotericin B with phospholipid membranes containing or not ergosterol: new insight, into them role of ergosterol
J Milhaud et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2002)
Amphotericin biosynthesis in Streptomyces nodosus:: deductions from analysis of polyketide synthase and late genes
P Caffrey et al.
CHEMISTRY & BIOLOGY (2001)
Share Paper
